Advertisements

Protalix BioTherapeutics Inc. (DE) (PLX) Stock Quote

Detailed Quote for Protalix BioTherapeutics Inc. (DE) (PLX)
$ 0.76   -0.01 (-1.30%) Volume: 521.69k 4:03 PM EDT Jul 20, 2017
After Hours:  $ 0.76 0.00 (0.00%) Volume: 45k 5:06 PM EDT Jul 20, 2017
Today 5d 1m 3m 1y more
Last Price
0.76
Change $
0.01
Change %
1.30%
Tick
  
Bid
0.683
Bid Size
100
Ask
0.98
Ask Size
6,100
Open
0.7777
High
0.7777
Low
0.73
Prev Close
0.77
Last Trade
07/20/17
Volume
521.69k
52 Wk Hi
1.51460003
52 Wk Low
0.25999999
Market Cap
96.14m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
126,499,455
EPS (TTM)
-0.680000007
PE Ratio
N/A
Exchange
NYSE American
News and Media for Protalix BioTherapeutics Inc. (DE) (PLX)
Sector News | Topic News
News for Protalix BioTherapeutics Inc. (DE) (PLX)
Thu, Jul 20, 2017
4:50 PM Protalix Is Undervalued With Upcoming Catalysts - SeekingAlpha
Mon, Jul 03, 2017
6:55 AM Wall Street Breakfast: Tesla Gears Up For Model 3 - SeekingAlpha
Fri, Jun 30, 2017
7:54 AM ProCellEx Has The Potential To Upend The Biopharmaceutical Sector - SeekingAlpha
Sat, Jun 24, 2017
8:58 AM Stocks to watch next week - SeekingAlpha
Wed, Jun 21, 2017
7:38 AM Amicus Therapeutics: Elucidating The Bullish And Bearish Claims - SeekingAlpha
Thu, Jun 08, 2017
1:36 PM Protalix BioTherapeutics (PLX) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow - SeekingAlpha
Wed, Jun 07, 2017
7:30 AM Protalix BioTherapeutics Announces Phase II Clinical Trial Results for alidornase alfa in Cystic Fibrosis Presented at the 40th European Cystic Fibrosis Society Conference - GlobeNewswire
Tue, Jun 06, 2017
7:55 AM Exelixis: Substantial Unlocked Value In The Cabozantinib Franchises - SeekingAlpha
Thu, Jun 01, 2017
7:30 AM Protalix BioTherapeutics Announces FDA Approval to Operate its Current Facility\u00A0as a Multi-Product Facility - GlobeNewswire
Wed, May 31, 2017
12:28 PM Protalix BioTherapeutics: A Novel Enzymes Innovator For Orphan Diseases - SeekingAlpha
Mon, May 29, 2017
7:10 AM Congo clears Merck's Ebola vaccine - SeekingAlpha
Thu, May 25, 2017
7:30 AM Protalix BioTherapeutics to Present at the Jefferies 2017 Global Healthcare Conference - GlobeNewswire
Tue, May 23, 2017
7:30 AM Protalix BioTherapeutics Announces Presentation of Phase II Clinical Trial Results for alidornase alfa in Cystic Fibrosis at the 40th European Cystic Fibrosis Society Conference - GlobeNewswire
Wed, May 10, 2017
2:41 PM Protalix BioTherapeutics' (PLX) CEO Moshe Manor on Q1 2017 Results - Earnings Call Transcript - SeekingAlpha
7:33 AM Protalix BioTherapeutics misses by $0.39, beats on revenue - SeekingAlpha
7:30 AM Protalix BioTherapeutics Reports 2017 First Quarter Results and Provides Corporate Update - GlobeNewswire
Tue, May 09, 2017
7:30 AM Protalix Announces FDA Investigational New Drug Clearance to Commence\u00A0Once-Monthly Dosing Study of pegunigalsidase alfa (PRX-102) for the Treatment of Fabry Disease - GlobeNewswire
Mon, May 01, 2017
7:49 AM Protalix BioTherapeutics to Hold First Quarter 2017 Financial Results and Corporate Update Conference Call on May 10, 2017 - GlobeNewswire
Thu, Apr 20, 2017
8:17 PM Protalix BioTherapeutics Is Positioned Well For The Future - SeekingAlpha
Tue, Apr 18, 2017
7:30 AM Protalix BioTherapeutics Announces New Preclinical Results Demonstrating a Positive Effect of pegunigalsidase alfa (PRX-102) on Small-fiber Neuropathy in Fabry Disease Models Compared to Commercially Available Enzyme Replacement Therapies - GlobeNewswire
More News for PLX >>

Tags for Protalix BioTherapeutics Inc. (DE)

Research stocks or mutual funds related to Protalix BioTherapeutics Inc. (DE) by keywords or tags. Find companies that have a similar focus to PLX. The keywords below have been associated to PLX by either user submission or electronic means.

biotechnology company biotech research pharmaceuticals research pharmaceuticals international research patent market pharmaceutical market corporate communication generic pharmaceutical pharmaceutical investment pharma strategy biotechnology market pharmaceutical research and development annual report pharmaceutical manufacturing company dupont pharmaceuticals pharmaceutical advisory boards Biological Products pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license pharmaceutical supply chain kv pharmaceutical company clinical research pharmaceutical cro pharmaceutical sales pharmaceutical distributors biotech corporation pharmaceutical development pharmaceutical sales rep pharmaceutical reports pharmaceutical magazine pharma product development pharmaceutical patent Drugs pharmaceutical industry news pharmaceutical manufacturing software corporate communications pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharma reports publicity contract pharmaceutical pharmaceutical consulting pharmaceutical industry news release pharmaceutical studies pharmaceutical strategy